Incyte Corp (INCY) stock
INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$119.09−1.18 (-0.98%)
Close on Nov 17, 2026Market cap $24.27BP/E 63.3Yield –
Incyte cash
Cash and short-term investments held at the end of each period.
Incyte's cash was $3.28B at Sep 30, 2026. For fiscal 2025 it was $3.10B, up 83.4% from the year before. Over ten years it grew 15.7% a year on average. The highest annual figure on record is $3.66B in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.10B | +83.4% |
| FY2024 | Dec 31, 2024 | $1.69B | -53.8% |
| FY2023 | Dec 31, 2023 | $3.66B | +12.9% |
| FY2022 | Dec 31, 2022 | $3.24B | +37.9% |
| FY2021 | Dec 31, 2021 | $2.35B | +30.3% |
| FY2020 | Dec 31, 2020 | $1.80B | -14.9% |
| FY2019 | Dec 31, 2019 | $2.12B | +47.2% |
| FY2018 | Dec 31, 2018 | $1.44B | +23.0% |
| FY2017 | Dec 31, 2017 | $1.17B | +44.6% |
| FY2016 | Dec 31, 2016 | $809.43M | +12.0% |
| FY2015 | Dec 31, 2015 | $722.69M | +20.4% |
| FY2014 | Dec 31, 2014 | $600.26M | +17.9% |
| FY2013 | Dec 31, 2013 | $509.00M | +122.8% |
| FY2012 | Dec 31, 2012 | $228.42M | -17.7% |
| FY2011 | Dec 31, 2011 | $277.59M | -34.6% |
| FY2010 | Dec 31, 2010 | $424.17M | -5.7% |
| FY2009 | Dec 31, 2009 | $449.82M | +151.6% |
| FY2008 | Dec 31, 2008 | $178.77M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.28B | +33.3% |
| Q2 FY2026 | Jun 30, 2026 | $3.98B | +103.5% |
| Q1 FY2026 | Mar 31, 2026 | $3.46B | +78.1% |
| Q4 FY2025 | Dec 31, 2025 | $3.10B | +83.4% |
| Q3 FY2025 | Sep 30, 2025 | $2.46B | +38.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.96B | +34.8% |
| Q1 FY2025 | Mar 31, 2025 | $1.94B | -49.6% |
| Q4 FY2024 | Dec 31, 2024 | $1.69B | -53.8% |
| Q3 FY2024 | Sep 30, 2024 | $1.77B | -49.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.45B | -57.6% |
| Q1 FY2024 | Mar 31, 2024 | $3.85B | +23.7% |
| Q4 FY2023 | Dec 31, 2023 | $3.66B | +12.9% |
| Q3 FY2023 | Sep 30, 2023 | $3.52B | +18.1% |
| Q2 FY2023 | Jun 30, 2023 | $3.43B | +25.7% |
| Q1 FY2023 | Mar 31, 2023 | $3.11B | +22.3% |
| Q4 FY2022 | Dec 31, 2022 | $3.24B | +37.9% |
| Q3 FY2022 | Sep 30, 2022 | $2.98B | +30.3% |
| Q2 FY2022 | Jun 30, 2022 | $2.72B | +30.8% |
| Q1 FY2022 | Mar 31, 2022 | $2.55B | +29.6% |
| Q4 FY2021 | Dec 31, 2021 | $2.35B | +30.3% |
| Q3 FY2021 | Sep 30, 2021 | $2.29B | +31.6% |
| Q2 FY2021 | Jun 30, 2021 | $2.08B | +30.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.96B | +50.5% |
| Q4 FY2020 | Dec 31, 2020 | $1.80B | -14.9% |
| Q3 FY2020 | Sep 30, 2020 | $1.74B | -12.6% |
| Q2 FY2020 | Jun 30, 2020 | $1.59B | -6.2% |
| Q1 FY2020 | Mar 31, 2020 | $1.31B | -17.5% |
| Q4 FY2019 | Dec 31, 2019 | $2.12B | +47.2% |
| Q3 FY2019 | Sep 30, 2019 | $1.99B | +44.4% |
| Q2 FY2019 | Jun 30, 2019 | $1.70B | +41.5% |
| Q1 FY2019 | Mar 31, 2019 | $1.58B | +35.0% |
| Q4 FY2018 | Dec 31, 2018 | $1.44B | +23.0% |
| Q3 FY2018 | Sep 30, 2018 | $1.38B | +7.3% |
| Q2 FY2018 | Jun 30, 2018 | $1.20B | +96.8% |
| Q1 FY2018 | Mar 31, 2018 | $1.17B | +128.5% |
| Q4 FY2017 | Dec 31, 2017 | $1.17B | +44.6% |
| Q3 FY2017 | Sep 30, 2017 | $1.28B | – |
| Q2 FY2017 | Jun 30, 2017 | $609.55M | – |
| Q1 FY2017 | Mar 31, 2017 | $512.86M | – |
| Q4 FY2016 | Dec 31, 2016 | $809.43M | – |
See a number that looks wrong?